申请人:BEECHAM GROUP PLC
公开号:EP0101199A1
公开(公告)日:1984-02-22
A compound of formula (I) or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof:
wherein R represents an alkyl or aralkyl group, substituted on an alkyl carbon atom other than that adjacent to -NH- group, with one or more functional groups selected from halogen, non-aromatic heterocyclyl linked through carbon, aromatic heterocyclyl, nitro, oxo, -OR1, SR1, -P(0)R2R3, -NR4R5, =NR6, or a sulphur linked organic radical, wherein R1, R2, R3, R4, R5 and R6 are various organic radicals.
Processes for the preparation of these compounds and pharmaceutical compositions containing them are also disclosed.
式 (I) 的化合物或其药学上可接受的盐或体内可水解的酯:
其中 R 代表烷基或芳烷基,在与-NH-基团相邻的烷基碳原子上被一个或多个官能团取代,官能团选自卤素、通过碳连接的非芳香杂环基、芳香杂环基、硝基、氧代、-OR1、SR1、-P(0)R2R3、-NR4R5、=NR6 或硫连接的有机基,其中 R1、R2、R3、R4、R5 和 R6 是各种有机基。
此外,还公开了制备这些化合物和含有这些化合物的药物组合物的工艺。